ArticleTherapeutic advances in medical oncology2020

A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.

Xiaoyan Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.